Launch week offerEnds in00h00m00s

annual Promonthly Pro

Isao Oze

Has grant

Unit Leader

Aichi Cancer Center

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Biostatistics Biostatistics professors in Japan

Recent Grants

Grant: Close

クローン性造血と生活習慣曝露、生活習慣病リスクとの関連を解明する研究

Open Date: 2018-04-01

Close Date: 2021-03-31

Grant: Close

胃がん・大腸がんサバイバーコホート研究による、予後改善に繋がる要因の探索

Open Date: 2017-04-01

Close Date: 2019-03-31

Grant: Close

Exploration of lifestyle and psycho-social factors associated with prognosis of patients with gastric cancer

Open Date: 2014-04-01

Close Date: 2017-03-31

Grant: Close

Estabishment of dose volume constraints of organs at risk in image-guided intensity-modulated radiation therapy for prostate cancer

Open Date: 2013-04-01

Close Date: 2015-03-31

Grant: Close

The association between ADH7 polymorphisms and alcohol consumption

Open Date: 2010-01-01

Close Date: 2011-12-31

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

JAPAN

View details

Shogen Boku

Lecturer

Osaka University Hospital

JAPAN

View details

Yuriko N Koyanagi

Aichi Cancer Center

JAPAN

View details

Kohta Suzuki

Professor

Aichi Medical University

JAPAN

View details

Kaname Watanabe

Kanagawa Cancer Center

JAPAN

View details

Hidemi Ito

Division Chief

Aichi Cancer Center

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Isao Oze

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

Trends in net survival for 1,834,894 patients with cancer from 16 population-based cancer registries in Japan, 2000–14 (CONCORD-3)

Trends in net survival for cancers of the colon and rectum in Japan, 2000–14 (CONCORD-3)

Trends in net survival for cancers of the liver and pancreas in Japan, 2000–14 (CONCORD-3)

Trends in net survival for patients with stomach cancer in Japan, 2000–14 (CONCORD-3)

Trends in net survival for prostate cancer in Japan, 2000–14 (CONCORD-3)

Trends in net survival of patients with cutaneous melanoma in Japan, 2000–14 (CONCORD-3)

Trends in survival for children with brain tumors, acute lymphoblastic leukemia, and lymphomas in Japan, 2000–14 (CONCORD-3)

Trends in survival for patients with esophageal cancer in Japan, 2000–14 (CONCORD-3)

Trends in survival for patients with lung cancer in Japan, 2000–14 (CONCORD-3)

Helicobacter pylori Infection and the Risk of Biliary Tract and Pancreatic Cancers: Subsite‐Specific Associations in a Japanese Population

Differential Impact of BMI‐Associated Genetic Variants on Breast Cancer Risk: Insights From Mediation Analysis

Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101)

Trends in net survival for patients with brain tumors in Japan, 2000–14 (CONCORD-3)

Changes in seeking smoking cessation therapy among Japanese employees and their families: a possible role for the dissemination of heated tobacco products (HTPs)

Association between dairy intake and all-cause and cause-specific mortality: a pooled analysis of 0.4 million Japanese adults from 10 population-based cohort studies

Comparative Net Survival Analysis of Men and Women With Breast Cancer in Japan: A Population‐Based Study

Phase II trial on nivolumab plus hypofractionated radiotherapy in patients with metastatic mucosal melanoma: PORTER-M3 trial

Association Between Awareness of Limiting Food Intake and All-cause Mortality: A Cohort Study in Japan

A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol

Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

Collaborators (13)

Marisa Nishio

Tomoya Yokota

Go Makimoto

Kayo Nakata

Yukai Lu

Sarah K. Abe

Takashi Kimura

Keitaro Tanaka

Shogen Boku

Yuriko N Koyanagi

Kohta Suzuki

Kaname Watanabe

Hidemi Ito

Make your next move.